Literature DB >> 6171597

Characterization of a monoclonal antibody to human alpha-fetoprotein and its use in affinity chromatography.

U H Stenman, M L Sutinen, R K Selander, K Tontti, J Schröder.   

Abstract

A hybrid cell line secreting monoclonal antibodies to human alpha- fetoprotein (AFP) was produced by fusion of a mouse myeloma cell line with spleen cells from a BALB/c mouse immunized with human AFP. The affinity constant of the antibody was about 1.7 X 10(9) l/mol. When clones were grown in vitro, the highest concentration of specific antibody in the culture medium was 25 microgram/ml. A clone was transplanted intraperitoneally into pristine-primed BALB/c recipients. Ascites developed within 3-4 weeks of transplantation, and the maximal antibody concentration in the ascitic fluid was 2.5 mg/ml. The immunoglobulin fraction of ascitic fluid was coupled to cyanogen bromide-activated Sepharose and used for affinity chromatography of AFP. AFP containing less than 1% contaminating proteins was obtained by passing amniotic fluid through the column and eluting the adsorbed AFP with 4 mol/l urea. The monoclonal antibody was used for radioimmunoassay (RIA). The sensitivity obtained was 50 microgram/l, which is adequate for certain clinical applications.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171597     DOI: 10.1016/0022-1759(81)90319-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Antigenic analysis of woodchuck hepatitis virus surface antigen with site-specific radioimmunoassays.

Authors:  P J Cote; R E Engle; C A Langer; A Ponzetto; J L Gerin
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

2.  A beta-turn in alpha-amanitin is the most important structural feature for binding to RNA polymerase II and three monoclonal antibodies.

Authors:  K Baumann; G Zanotti; H Faulstich
Journal:  Protein Sci       Date:  1994-05       Impact factor: 6.725

3.  Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients.

Authors:  Shin Yazawa; Ryo Takahashi; Takehiko Yokobori; Rie Sano; Akira Mogi; Abby R Saniabadi; Hiroyuki Kuwano; Takayuki Asao
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.